Showing results (41-50 of 360) with videos related to
Sort By:
Pageof 36
Journal of Translational Medicine|December 4, 2016
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantationVikram M Raghunathan, Iris Sheng, Seah H LimBMC Chemistry|August 7, 2019
Analysis of chemical constituents in mainstream bidi smokeOmobola Ajoke Oladipupo, Dibyendu Dutta, Ngee Sing ChongThe American Journal of Hospice & Palliative Care|March 10, 2007
Medical condition is related to treatment preference in cancer patients: implications for quality assessmentJames E Rohrer, Seah H Lim, Frank Andrew BockAmerican Journal of Hematology|August 27, 2017
Changes in intestinal microbiota and their effects on allogeneic stem cell transplantationRory M Shallis, Christopher M Terry, Seah H LimClinical Nephrology|February 10, 2018
Successful use of rituximab in glomerular basement membrane nephritis associated with HIV interstitial nephritis secondary to Castleman diseaseNathan Calabro, Kammi Henriksen, Seah H Lim, et al.Microbiome|December 9, 2021
Signature changes in gut microbiome are associated with increased susceptibility to HIV-1 infection in MSMYue Chen, Huang Lin, Mariah Cole, et al.Leukemia & Lymphoma|November 12, 2010
A phase II study of low dose intravenous clofarabine for elderly patients with myelodysplastic syndrome who have failed 5-azacytidineSeah H Lim, John Mcmahan, Jian Zhang, et al.Ejhaem|November 29, 2023
Returning to employment following allogeneic hematopoietic stem cell transplant: A major problem among survivorsLuis Filgueira, Amir Steinberg, Rochelle Mendonca, et al.Leukemia Research|July 8, 2008
Core promoter sequence of SEMG I spans between the two putative GATA-1 binding domains and is responsive to IL-4 and IL-6 in myeloma cellsYana Zhang, Zhiqing Wang, Jian Zhang, et al.International Journal of Cancer|September 28, 2005
SPAN-Xb expression in myeloma cells is dependent on promoter hypomethylation and can be upregulated pharmacologicallyZhiqing Wang, Jian Zhang, Yana Zhang, et al.Pageof 36